National Cancer Research Institute

209.8k citations
5.6k papers ·

Impact in

    • Carcinogens and Genotoxicity Assessment
    • MicroRNA in disease regulation
    • Cancer Genomics and Diagnostics
  • Oncology top 2%
    • Cancer-related Molecular Pathways

Papers in

    • Cancer-related Molecular Pathways 235
    • Carcinogens and Genotoxicity Assessment 197
    • Cancer Genomics and Diagnostics 193

National Cancer Research Institute

5.0k papers receiving 185.9k citations

Peers

National Cancer Research Institute
Comparison fields: 5 of 240
  • Cancer Research 33.3k
  • Oncology 47.4k
  • Molecular Biology 87.0k
  • Immunology 18.9k
  • Hepatology 6.5k
Replace GlaxoSmithKline (United Kingdom) with:
GlaxoSmithKline (United Kingdom) United Kingdom
AstraZeneca (United Kingdom) United Kingdom
The Christie Hospital United Kingdom
Cancer Research UK Manchester Institute United Kingdom
MRC Clinical Trials Unit at UCL United Kingdom
CRUK Lung Cancer Centre of Excellence United Kingdom
Sanofi (France) France
The Christie NHS Foundation Trust United Kingdom
William Harvey Research Institute United Kingdom
Institut Pasteur de Lille France
National Cancer Research Institute relative to GlaxoSmithKline (United Kingdom) United Kingdom GlaxoSmithKline (United Kingdom)'s profile →
Citations per field
00.5×1.5×2.0×
GlaxoSmithKline (United Kingdom) · 1×
Citations per year

Countries citing scholars working at National Cancer Research Institute

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at National Cancer Research Institute. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at National Cancer Research Institute with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites National Cancer Research Institute more than expected).

Fields of papers published by authors at National Cancer Research Institute

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with National Cancer Research Institute at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with National Cancer Research Institute at the time of their publication.

About National Cancer Research Institute

In recent decades, authors affiliated with National Cancer Research Institute have published 5.6k papers, which have received a total of 209.8k indexed citations . Scholars at this organization have produced 1.4k papers in Oncology, 772 papers in Cancer Research, 2.0k papers in Molecular Biology, 767 papers in Pulmonary and Respiratory Medicine and 403 papers in Pathology and Forensic Medicine on the topics of Cancer-related Molecular Pathways (235 papers), DNA Repair Mechanisms (219 papers), RNA modifications and cancer (218 papers), Carcinogens and Genotoxicity Assessment (197 papers), Epigenetics and DNA Methylation (194 papers), Cancer Genomics and Diagnostics (193 papers), Lung Cancer Treatments and Mutations (173 papers) and Sarcoma Diagnosis and Treatment (171 papers). Their work is cited by papers focused on Cancer Research (33.3k citations), Oncology (47.4k citations), Molecular Biology (87.0k citations), Immunology (18.9k citations) and Hepatology (6.5k citations). Authors at National Cancer Research Institute collaborate with scholars in United Kingdom, Japan and United States and have published in prestigious journals including Japanese Journal of Clinical Oncology, Cancer Science, Carcinogenesis, International Journal of Cancer and Nucleic Acids Research. Some of National Cancer Research Institute's most productive authors include Takashi Sügimura, Setsuo Hirohashi, Susumu Nishimura, Yae Kanai, Takahiro Ochiya, Yoichi Taya, Toshikazu Ushijima, Hiroshi Kasai, Yukío Shimosato and Claudia Bolognesi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact